YTYan Tang

Yan Tang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yan Tang has a total of 65 co-authors. Here are the top co-authors by number of shared publications:

  • Qi-Qun Tang

    Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Department of Biochemistry and Molecular Biology of School of Basic Medical Sciences and Department of Endocrinology and Metabolism of Zhongshan Hospital, Fudan University, Shanghai 200032, China

    5 shared publications
  • Shuwen Qian

    Key Laboratory of Metabolism and Molecular Medicine of the Ministry of Education, Department of Biochemistry and Molecular Biology of School of Basic Medical Sciences and Department of Endocrinology and Metabolism of Zhongshan Hospital, Fudan University, Shanghai, China

    4 shared publications
  • Yang Liu

    Key Laboratory of Metabolism and Molecular Medicine of the Ministry of Education, Department of Biochemistry and Molecular Biology of School of Basic Medical Sciences and Department of Endocrinology and Metabolism of Zhongshan Hospital, Fudan University, Shanghai, China

    4 shared publications
  • Hong Ma

    Key Laboratory of Metabolism and Molecular Medicine of the Ministry of Education, Department of Biochemistry and Molecular Biology of School of Basic Medical Sciences, and Institutes of Biomedical Sciences, Fudan University, Shanghai, China

    3 shared publications
  • Linyuan Wang

    Key Laboratory of Metabolism and Molecular Medicine of the Ministry of Education, Department of Biochemistry and Molecular Biology of School of Basic Medical Sciences, and Institutes of Biomedical Sciences, Fudan University, Shanghai, China

    2 shared publications
  • Mengyuan Dai

    Department of Immunology, Shanghai Medical College, Fudan University, Shanghai, China

    2 shared publications

Latest Publications

  • Open Access

    Hierarchical Chemical Ordering Enables Ultra‐Efficient Strengthening and Multifunctionality

    by Meng Li, Yi‐Nan Wang, Yan Tang, Yang He, Jian‐Xin Hou, Yu‐Bo Huang, Fu‐Zhi Dai, Shi‐Lei Li, Hai‐Jun Zhang, Yan‐Dong Wang, et al.

    Modern alloy design increasingly seeks substantial strengthening with minimal alloying to improve sustainability while preserving or enhancing matrix functionality, an imperative for high‐end applications like biodegradable implants. Yet for over half a century, strengthening has relied on introducing intensive defects via heavy alloying to impede dislocations; unfortunately, those defects inevitably induce functional degradation, producing a persistent strength‐functionality trade‐off. Here, we transform grain boundary (GB) sliding, typically a source of softening, into an ultra‐efficient strengthening mechanism via engineered hierarchical chemical ordering (HCO). In a model biodegradable near‐pure Zn alloy with only 0.17 at.% solute (Zn‐0.12Mg‐0.05Mn), yield strength increases tenfold to 350 MPa and represents the largest gain for ultra‐lean alloys below 0.5 at.% while exceeding clinical benchmarks. The alloy delivers 32% elongation and uniform biodegradation that exceeds even what was long considered exclusive to pure metals, with 10%–37% higher cell viability, 38% enhanced wound healing, and uncompromised electrical conductivity. The HCO achieves dual‐range strengthening as intragranular Mn‐rich nanoclusters elevate GB motion stress by ∼164% through long‐range suppression of stress relaxation, while Mg segregation at GBs increases critical sliding stress by ∼600% via short‐range pinning. This mechanism bypasses traditional strength‐functionality trade‐offs, establishing a new design paradigm for ultra‐lean, high‐performance alloys.

  • Open Access

    Deleting Bmp4 in brown fat unlocks an arachidonic acid-AMPK axis to boost energy expenditure

    by Yan-Jue Song, Ting Meng, Zhen-Yu Xu, Ting Zhang, Zhao-Ning Wang, Dai-Chen Yao, Li-Jie Yang, Ping Wu, Shu-Wen Qian, Yang Liu, et al.


  • Open Access

    Palmitoleic acid promoted by BMPR2 signaling primes CD169 macrophages and alleviates liver fibrosis

    by Hong Ma, Jinkun Zhong, Qilin Peng, Mengyuan Dai, Linyuan Wang, Jianan Wang, Danchun Huang, Yang Liu, Yan Tang, Wei Xu, et al.

    Bone morphogenetic proteins (BMPs) participate in the energy metabolism. BMP receptor type 2 (BMPR2) is expressed in the liver. Whether BMPR2 is involved in the pathophysiology of nonalcoholic fatty liver disease (NAFLD) has not been studied. In this study, we analyzed the RNA-sequence data of several patient cohorts and found that BMPR2 expression decreases at the stages of advanced fibrosis. A mouse model featuring BMPR2 knockout demonstrate that BMPR2 knockout in the liver produces profibrotic effect upon long-term high-fat and high-fructose (HFF) diet challenge. BMP signaling promotes biosynthesis of unsaturated fatty acids, which is repressed under BMPR2 knockout condition. The most affected unsaturated fatty acid, palmitoleic acid (POA), is found to activate CD169 macrophages. Moreover, CD169 macrophages is revealed to have high levels of lysosomal enzyme along with matrix metalloproteinase 8, which degrades collagen and alleviates fibrosis. Our study demonstrates that BMPR2 influences over the progression of liver fibrosis induced by the HFF diet through fatty acid-regulated CD169 macrophages. POA-primed macrophages might be a potential therapeutic strategy for the treatment of liver fibrosis.


  • Open Access

    A single-cell sequence analysis of mouse subcutaneous white adipose tissue reveals dynamic changes during weaning

    by Shuwen Qian, Chenyang Zhang, Yan Tang, Mengyuan Dai, Zhihui He, Hong Ma, Linyuan Wang, Qiqi Yang, Yang Liu, Wei Xu, et al.

    Adipose tissue development begins in the fetal period, and continues to expand after birth. Dysregulation of adipose tissue during weaning may predispose individuals to lifelong metabolic disorders. However, the developmental remodeling of adipose tissue during weaning remains largely unexplored. Here we comprehensively compare the changes in mouse subcutaneous white adipose tissue from 7 days after birth to 7 days after weaning using single-cell RNA sequencing along with other molecular and histologic assays. We characterize the developmental trajectory of preadipocytes and indicate the commitment of preadipocytes with beige potential during weaning. Meanwhile, we find immune cells unique to weaning period, whose expression of extracellular matrix proteins implies potential regulation on preadipocyte. Finally, the strongest cell-cell interaction during weaning determined by the TGFβ ligand-receptor pairs is between preadipocytes and endotheliocytes. Our results provide a detailed and unbiased cellular landscape and offer insights into the potential regulation of adipose tissue remodeling during weaning.


  • Top Cited Papers

    Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction

    by Yang Liu, Jing-Jing Jiang, Shao-Yue Du, Liang-Shan Mu, Jian-Jun Fan, Jun-Chi Hu, Yao Ye, Meng Ding, Wei-Yu Zhou, Qiu-Han Yu, et al.

    Polycystic ovary syndrome (PCOS), a prevalent reproductive disorder in women of reproductive age, features androgen excess, ovulatory dysfunction, and polycystic ovaries. Despite its high prevalence, specific pharmacologic intervention for PCOS is challenging. In this study, we identified artemisinins as anti-PCOS agents. Our finding demonstrated the efficacy of artemisinin derivatives in alleviating PCOS symptoms in both rodent models and human patients, curbing hyperandrogenemia through suppression of ovarian androgen synthesis. Artemisinins promoted cytochrome P450 family 11 subfamily A member 1 (CYP11A1) protein degradation to block androgen overproduction. Mechanistically, artemisinins directly targeted lon peptidase 1 (LONP1), enhanced LONP1-CYP11A1 interaction, and facilitated LONP1-catalyzed CYP11A1 degradation. Overexpression of LONP1 replicated the androgen-lowering effect of artemisinins. Our data suggest that artemisinin application is a promising approach for treating PCOS and highlight the crucial role of the LONP1-CYP11A1 interaction in controlling hyperandrogenism and PCOS occurrence.


  • Slit3 secreted from M2-like macrophages increases sympathetic activity and thermogenesis in adipose tissue

    by Yi-Na Wang, Yan Tang, Zhihui He, Hong Ma, Linyuan Wang, Yang Liu, Qiqi Yang, Dongning Pan, Cuiqing Zhu, Shuwen Qian, et al.

    Beiging of white adipose tissue (WAT) is associated with an increase of anti-inflammatory M2-like macrophages in WAT. However, mechanisms through which M2-like macrophages affect beiging are incompletely understood. Here, we show that the macrophage cytokine Slit3 is secreted by adipose tissue macrophages and promotes cold adaptation by stimulating sympathetic innervation and thermogenesis in mice. Analysing the transcriptome of M2-like macrophages in murine inguinal WAT (iWAT) after cold exposure, we identify Slit3 as a secreted cytokine. Slit3 binds to the ROBO1 receptor on sympathetic neurons to stimulate Ca2+/calmodulin-dependent protein kinase II signalling and norepinephrine release, which enhances adipocyte thermogenesis. Adoptive transfer of Slit3-overexpressing M2 macrophages to iWAT promotes beiging and thermogenesis, whereas mice that lack Slit3 in myeloid cells are cold-intolerant and gain more weight. Our findings shed new light on the integral role of M2-like macrophages for adipose tissue homeostasis and uncover the macrophage–Slit3–sympathetic neuron–adipocyte signalling axis as a regulator of long-term cold adaptation.